A tumor microenvironment-activatable nanoplatform with phycocyanin-assisted in-situ nanoagent generation for synergistic treatment of colorectal cancer
Xiaoxiao Sun,Xiaoye Liang,YuKai Wang,Pengcheng Ma,Weiwei Xiong,Shiyu Qian,Yu Cui,Haiyang Zhang,Xiang Chen,Fang Tian,Yang Shi,Fenfen Zheng,Lingling Li
DOI: https://doi.org/10.1016/j.biomaterials.2023.122263
IF: 14
2023-08-02
Biomaterials
Abstract:The in-situ generation of therapeutic agents in targeted lesions is promising for revolutionizing oncotherapy but is limited by the low production efficiency. Given the specific tumor microenvironment (TME) of colorectal cancer (CRC), i . e ., mild acidity, overexpressed H 2 O 2 , glutathione (GSH) and H 2 S, we develop phycocyanin (PC) encapsulated PZTC/SS/HA nanocapsules (NCs) for TME-responsive, protein-assisted "turn-on'' therapy of CRC. The NCs are prepared by sequentially assembling Cu 2+ -tannic acid (TA) coordination shell, disulfide bond-bearing cross-linker, and hyaluronic acid (HA) on the sacrificial template ZIF-8, thus achieving pH-, GSH-responsiveness, and tumor targeting capability, respectively. Once reaching the CRC sites, the NCs can quickly disintegrate and release Cu 2+ and PC, accompanied by subsequent endogenous H 2 S-triggered generation of copper sulfide (CuS). Significantly, the intracellular sulfidation process can be accelerated by PC, thereby enabling efficient photothermal therapy (PTT) under NIR-II laser. Besides, Cu 2+ -associated chemodynamic therapy (CDT) can be simultaneously activated and enhanced by PTT-induced local hyperthermia and disulfide bond-induced GSH consumption. This CRC-targeted and TME-activated synergistic PTT/CDT strategy displays high therapeutic efficacy both in vitro and in vivo , which can open up a new avenue for biomolecule-assisted in-situ nanoagent generation and effective TME-responsive synergistic treatment of CRC.
engineering, biomedical,materials science, biomaterials